This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager NURSA Molecule Pages Link Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ochiai, E. Articles by Ishizuka, S. Search for Related Content PubMed PubMed Citation Articles by Ochiai, E. Articles by Ishizuka, S.

Molecular Mechanism of the Vitamin D Antagonistic Actions of (23S)-25-Dehydro-1-Hydroxyvitamin D₃-26,23-Lactone Depends on the Primary Structure of the Carboxyl-Terminal Region of the Vitamin D Receptor

Teijin Institute for Bio-Medical Research (E.O., D.M., H.E., S.O., K.T., Y.A., T.K., S.I.), Hino, Tokyo 191-8512, Japan; and Department of Biochemistry (A.W.N.) and Division of Biomedical Sciences, University of California, Riverside, California 92521

Address all correspondence and requests for reprints to: Dr. Anthony W. Norman, Department of Biochemistry University of California Riverside, California 92521 E-mail: Anthony.Norman{at}ucr.edu.

We reported that (23S)-25-dehydro-1-hydroxyvitamin D₃-26,23-lactone (TEI-9647) antagonizes vitamin D receptor (VDR)-mediated genomic actions of 1,25-dihydroxyvitamin D₃ [1,25(OH)₂D₃] in human cells but is agonistic in rodent cells. Human and rat VDR ligand-binding domains are similar, but differences in the C-terminal region are important for ligand binding and transactivation and might determine the agonistic/antagonistic effects of TEI-9647. We tested TEI-9647 on 1,25(OH)₂D₃ transactivation using SaOS-2 cells (human osteosarcoma) or ROS 24/1 cells (rat osteosarcoma) cotransfected with human or rodent VDR and a reporter. In both cell lines, TEI-9647 was antagonistic with wild-type human (h)VDR, but agonistic with overexpressed wild-type rat (r)VDR. VDR chimeras substituting the hVDR C-terminal region (activation function 2 domain) with corresponding rVDR residues diminished antagonism and increased agonism of TEI-9647. However, substitution of 25 C-terminal rVDR residues with corresponding hVDR residues diminished agonism and increased antagonism of TEI-9647. hVDR mutants (C403S, C410N) demonstrated that Cys403 and/or 410 was necessary for TEI-9647 antagonism of 1,25(OH)₂D₃ transactivation. These results suggest that species specificity of VDR, especially in the C-terminal region, determines the agonistic/antagonistic effects of TEI-9647 that determine, in part, VDR interactions with coactivators and emphasize the critical interaction between TEI-9647 and the two C-terminal hVDR Cys residues to mediate the antagonistic effect of TEI-9647.

NURSA Molecule Pages Link:

Nuclear Receptors:   VDR  |  RXRα

Coregulators:   SRC-1  |  GRIP1

Ligands:   Calcitriol

This article has been cited by other articles:

				A. I. Castillo, R. Sanchez-Martinez, A. M. Jimenez-Lara, A. Steinmeyer, U. Zugel, and A. Aranda Characterization of Vitamin D Receptor Ligands with Cell-Specific and Dissociated Activity Mol. Endocrinol., December 1, 2006; 20(12): 3093 - 3104. [Abstract] [Full Text] [PDF]